[Intralymphatic administration of estramustine phosphate].
Department of Obstetrics and Gynecology, Nihon University School of Medicine, Tokyo.
H
H
Sakamoto
K
K
Ohtani
J
J
Kawamori
T
T
Shirakawa
H
H
Ohta
N
N
Igarashi
M
M
Tochigi
K
K
Furuya
K
K
Tsubata
Y
Y
Tanaka
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004961:Estramustine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007272:Injections, Intralymphatic; D008207:Lymphatic Metastasis; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D018931:Antineoplastic Agents, Hormonal; D004961:Estramustine